AGP Executive Report
Last update: 8 hours agoPFAS Health Alert (Netherlands): RIVM reports PFAS found in all 1,629 Dutch breast milk samples, with 18% above the safe level—“shocking” results that link “forever chemicals” to cancer and hormone disruption, though levels are lower than in smaller earlier samples. Extreme Heat & Care Capacity: A Reuters report says Europe’s June heatwave exposed weak adaptation, with Spain reporting 1,000 excess deaths and disruptions to power, outdoor work bans, and rail problems—raising pressure on hospitals and public services. AI in Healthcare (Netherlands): A Philips Future Health Index finds 63% of Dutch clinicians feel their organisations are ready for AI, with reported capacity gains of about seven extra patients per week where AI helps. Medical Innovation (Netherlands-linked): Xeltis hit 50% enrolment in its US pivotal trial for aXess, a living vascular access device for hemodialysis, supported by FDA Breakthrough Device status. Healthcare Business (Halma): Halma announced two acquisitions—Dutch itemedical (€23m) and Sweden’s Naslund Medical ($45m)—to expand hospital software and cancer-targeting technology. Rare Birth (Máxima Medical Center): Máxima Medical Center in Noord-Brabant reports naturally conceived identical quadruplets (four boys) delivered at 29 weeks, a first for the neonatologist team.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
